<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01558622</url>
  </required_header>
  <id_info>
    <org_study_id>KVDU 0001 GG</org_study_id>
    <nct_id>NCT01558622</nct_id>
  </id_info>
  <brief_title>Intraoperative Use of Dexketoprofen Trometamol, Pethidine Hcl, Tramadol Hcl and Their Combinations for Postoperative Pain Management in Laparoscopic Nissen Fundoplication</brief_title>
  <official_title>Intraoperative Use of Dexketoprofen Trometamol, Tramadol Hcl, Pethidine Hcl and Their Combinations for Postoperative Pain Management in Laparoscopic Nissen Fundoplication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kavaklıdere Umut Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kavaklıdere Umut Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the analgesic effects of dexketoprofen trometamol,
      tramadol hydrochloride, pethidine hydrochloride and their combinations in laparoscopic Nissen
      fundoplication.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>March 2012</start_date>
  <primary_completion_date type="Anticipated">May 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Allergic reactions to NSAIDs or opioid analgesics, body mass index exceeding 35</measure>
    <time_frame>postoperative 2 hours</time_frame>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Laparoscopic Nissen Fundoplication</condition>
  <arm_group>
    <arm_group_label>dexketoprofen trometamol</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Dexketoprofen trometamol is a water-soluble salt of the dextrorotatory enantiomer of the nonsteroidal anti-inflammatory drug (NSAID) ketoprofen.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tramadol hydrochloride</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Tramadol Hydrochloride is a well-known centrally acting opioid pain killer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pethidine hydrochloride</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Pethidine is a synthetic opioid analgesic which produces a pattern of effects similar to morphine the standard against which opioid analgesics are compared.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dexketoprofen trometamol + tramadol hydrochloride</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>dexketoprofen trometamol + pethidine hydrochloride</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>vitamin c</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexketoprofen trometamol</intervention_name>
    <description>50mg intravenous infusion</description>
    <arm_group_label>dexketoprofen trometamol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tramadol hydrochloride</intervention_name>
    <description>100mg intravenous infusion</description>
    <arm_group_label>tramadol hydrochloride</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>pethidine hydrochloride</intervention_name>
    <description>50mg intravenous infusion</description>
    <arm_group_label>pethidine hydrochloride</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexketoprofen trometamol + tramadol hydrochloride</intervention_name>
    <description>intravenous infusion of 50mg dexketoprofen trometamol + 100mg tramadol hydrochloride</description>
    <arm_group_label>dexketoprofen trometamol + tramadol hydrochloride</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexketoprofen trometamol + pethidine hydrochloride</intervention_name>
    <description>intravenous infusion of 50mg dexketoprofen trometamol + 50mg pethidine hydrochloride</description>
    <arm_group_label>dexketoprofen trometamol + pethidine hydrochloride</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vitamin c</intervention_name>
    <description>500mg intravenous infusion</description>
    <arm_group_label>vitamin c</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-60 years old ASA I-II patients

          -  Clinical diagnosis of gastroesophageal reflux patients

        Exclusion Criteria:

          -  Allergic reactions to NSAIDs or opioid analgesics

          -  Body mass index exceeding 35

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GOKHAN GOKMEN, Specialist</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Kavaklidere Umut Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06660</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 16, 2012</study_first_submitted>
  <study_first_submitted_qc>March 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2012</study_first_posted>
  <last_update_submitted>March 22, 2012</last_update_submitted>
  <last_update_submitted_qc>March 22, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 23, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kavaklıdere Umut Hospital</investigator_affiliation>
    <investigator_full_name>GOKHAN GOKMEN</investigator_full_name>
    <investigator_title>Anesthesiologist, MD</investigator_title>
  </responsible_party>
  <keyword>postoperative analgesia</keyword>
  <keyword>dexketoprofen trometamol</keyword>
  <keyword>tramadol hydrochloride</keyword>
  <keyword>pethidine</keyword>
  <keyword>laparoscopic Nissen fundoplication</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Tramadol</mesh_term>
    <mesh_term>Meperidine</mesh_term>
    <mesh_term>Dexketoprofen trometamol</mesh_term>
    <mesh_term>Ketoprofen</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>July 27, 2012</submitted>
    <submission_canceled>Unknown</submission_canceled>
    <submitted>August 6, 2012</submitted>
    <submission_canceled>Unknown</submission_canceled>
    <submitted>August 11, 2012</submitted>
    <returned>September 10, 2012</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

